Norris Medicines informs about outcome of board meeting

15 Sep 2022 Evaluate
Norris Medicines has informed that the Board of Directors of the Company at its meeting held on Thursday, the 15th September, 2022 has granted its approval to make an application to Registrar of Companies for seeking extension of time to hold the Annual General Meeting for the financial year ended 31st March, 2022 by three months due to administrative reasons faced by the Company.

The above information is a part of company’s filings submitted to BSE.

Norris Medicines Share Price

13.82 -0.15 (-1.07%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×